Literature DB >> 18439686

Methohexitone, propofol and etomidate in electroconvulsive therapy for depression: a naturalistic comparison study.

Savithasri V Eranti1, Andrew J Mogg, Graham C Pluck, Sabine Landau, Declan M McLoughlin.   

Abstract

BACKGROUND: Methohexitone has been the most widely used anaesthetic for electroconvulsive therapy (ECT). However, recent scarcity and erratic availability has led to use of other anaesthetics with differing effects upon ECT. We compared treatment parameters and response to ECT in patients anaesthetised with different anaesthetics in a routine clinical setting.
METHODS: This was a naturalistic retrospective casenote analysis of 81 consecutive courses of ECT (total 659 treatments) for major depression.
RESULTS: Three anaesthetics were compared: methohexitone (n=34), propofol (n=13) and etomidate (n=34). Mean seizure duration was lowest (p<0.0001) for propofol. However, mean stimulus charge was highest in the propofol group (p<0.0001) who required a greater increase in stimulus charge during the course of treatment and also experienced a greater proportion of failed seizures (</=15 s on EEG). Despite differing effects upon treatment parameters, choice of anaesthetic did not appear to significantly affect therapeutic response to ECT. Use of propofol may be associated with longer treatment course that could result in extra cost. LIMITATIONS: This was a retrospective casenote study, in which patients were not randomised to anaesthetic and standardised outcome measures were not used. The small sample size in the propofol group may have reduced the power of the study to demonstrate other differences between propofol and the other anaesthetic groups. A formal economic analysis was not performed.
CONCLUSION: Individual anaesthetics differentially influence seizure duration and stimulus charge but final response to ECT appears not to be adversely affected.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18439686     DOI: 10.1016/j.jad.2008.03.004

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  7 in total

Review 1.  [Anesthesia for electroconvulsive therapy].

Authors:  U Grundmann; S O Schneider
Journal:  Anaesthesist       Date:  2013-04       Impact factor: 1.041

2.  Impact of the anesthetic agents ketamine, etomidate, thiopental, and propofol on seizure parameters and seizure quality in electroconvulsive therapy: a retrospective study.

Authors:  Carolin Hoyer; Laura Kranaster; Christoph Janke; Alexander Sartorius
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-07-09       Impact factor: 5.270

3.  The influence of anaesthetic choice on seizure duration of electroconvulsive therapy; etomidate versus methohexital.

Authors:  Laila Chomrikh; Mustafa Ahmadi; T Martijn Kuijper; Joris J B van der Vlugt; Seppe J H A Koopman
Journal:  BMC Anesthesiol       Date:  2022-07-05       Impact factor: 2.376

4.  Etomidate versus Propofol for Motor Seizure Duration during Modified Electroconvulsive Therapy.

Authors:  Seema Jindal; Gurkaran Kaur Sidhu; Samiksha Kumari; Preeti Kamboj; Rajeev Chauhan
Journal:  Anesth Essays Res       Date:  2020-06-22

Review 5.  Anesthetic care for electroconvulsive therapy.

Authors:  Kyoung-Woon Joung; Dong Ho Park; Chang Young Jeong; Hong Seuk Yang
Journal:  Anesth Pain Med (Seoul)       Date:  2022-04-15

Review 6.  Different regimens of intravenous sedatives or hypnotics for electroconvulsive therapy (ECT) in adult patients with depression.

Authors:  Peng Lihua; Min Su; Wei Ke; Patrick Ziemann-Gimmel
Journal:  Cochrane Database Syst Rev       Date:  2014-04-11

7.  Influence of valproate on the required dose of propofol for anesthesia during electroconvulsive therapy of bipolar affective disorder patients.

Authors:  Gökben Hızlı Sayar; Gül Eryılmaz; Siban Semieoğlu; Eylem Ozten; Işıl Göğcegöz Gül
Journal:  Neuropsychiatr Dis Treat       Date:  2014-03-04       Impact factor: 2.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.